sherlocka s diseases of the liver and biliary sys
gnosis. Development of non-invasive fibrosis assessment tools. Novel antiviral agents with shorter regimens. Regenerative medicine and stem cell therapies. Targeted therapies for autoimmune and cholestatic diseases.
